Orphina LLC

ORPHINA

Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the prevention of neuromuscular, neurological, musculoskeletal, genetic, metabolic, orthopedic, and oncologic diseases; Pharmaceutical preparations for the prevention of rare diseases; Pharmaceutical preparations for the prevention of muscle wasting and muscle degeneration; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of neuromuscular, neurological, musculoskeletal, genetic, metabolic, orthopedic, and oncologic diseases; Pharmaceutical preparations for the treatment of rare diseases; Pharmaceutical preparations for the treatment of muscle wasting and muscle degeneration; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for biologics, gene therapy, or stem cell therapy; Pharmaceutical preparations for muscle function improvement; Stem cells for medical purposes;

ORPHINA

Biotechnology research; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of new technology for others in the field of neuromuscular, neurological, musculoskeletal, genetic, metabolic, orthopedic, and oncologic diseases; Development of new technology for others in the field of muscle wasting and muscle degeneration; Development of new technology for others in the field of biologics, gene therapy, or stem cell therapy; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy;